Key Research Points at a Glance A 15-amino-acid fragment of a gastric-juice-derived protective protein, first characterised in the early 1990s Primary research mechanisms: angiogenesis (VEGF pathway) and gastric/gut-lining signalling Secondary mechanisms under study: growth factor modulation (EGF, FGF) and nitric oxide system interaction Frequently co-researched with TB-500 despite acting through an unrelated mechanism The large majority of published research is pre-clinical (in-vitro and animal-model), not human clinical data Notably stable across a wider pH/temperature range than many comparable research peptides What Is BPC-157
[DOI] [PubMed] [Google Scholar] Kasparek P., Ileninova Z., Zbodakova O., Kanchev I., Benada O., Chalupsky K., et al
Aftward, you will receive monthly maintenance shots
Safety Profile and Possible Side Effects Preclinical studies show BPC-157 was well-tolerated with no serious toxicity in mice, rats, rabbits, and dogs
Patients, patient representatives, and care partners will share their experiences with nonhealing chronic wounds during the meeting, and attendees will learn how the condition affects patient health, current treatments, and clinical trial considerations